Abstract:e17019 Background: Ataxia telangiectasia-mutated（ATM）is a serine/threonine kinase involved in DNA-damage repair (DDR) system and regulating cell cycle checkpoints, senescence, and apoptosis. Several clinical studies provide evidence about the DDR-mutated metastatic castration-resistant prostate cancer (mCRPC) benefit from PARP inhibitors (PARPi). However. the efficacy of PARPi was limited for mCRPC patients harboring ATM aberrations. We aimed to determine the association of ATM mutations with clinical and molecular features in patients with mCRPC. Methods: A total of three independent prostate cancer cohorts (MCTP, N = 61; SU2C-PCF, N = 429; MSKCC, N = 451) were used for analysis. We selected patients with characteristics “mCRPC” and “histology type: prostate adenocarcinoma”. Both the somatic and germline pathogenic alterations were analyzed, including single nucleotide variations (SNVs), in-frame insertions or deletions (Indels), frameshifts, homozygous deletions and fusions. The statistical analysis was conducted by R software (v.3.6.2). Results: We merged the three mCRPC cohorts, generating a new cohort consisting of 507 mCRPC patients. The median age was 62 (range, 38.6-89). The number of biopsies was 1-3 per patient. Of the 527 sequenced specimens, 39% were lymph node, 27% were bone, and 14% were liver. Forty percent of the patients had exposed to or on-treatment with next-generation androgen receptor signaling inhibitor (ARSI). A total of 44 patients (8.7%) harbored deleterious variations in ATM, including 10 homozygous deletions. The coexistence mutations were most commonly located in androgen receptor ( AR), followed by TTN/KMT2C/MUC16/TP53. Furthermore, we explored the association of pathogenic ATM alterations with clinical features. Compared with noncarriers of ATM mutations , carriers were diagnosed at a younger age (median: 59 vs 62.4, P = 0.022). In the subgroup from SU2C-PCF cohort, prostate specific antigen (PSA) at diagnosis and the proportion of Gleason score between 8-10 were analyzed, both showed no significant differences between the two groups. Notably, we observed a statistically significant higher TMB in ATM-altered group than ATM wildtype group (median, 2.04 vs 1.61, P = 0.013). Overall survival (OS) was not compared because of the limited clinical outcomes in ATM-mutated population. Conclusions: This study involving 3 cohorts identified the prevalence of pathogenic somatic or germline ATM mutations and explored the association of ATM alterations with both clinical and molecular features. Patients with ATM mutations tended to diagnose prostate cancer at an earlier age. Meanwhile, significantly higher TMB might imply potential immunotherapy opportunities in ATM-altered mCRPC without standard-of-care approaches.

Association of the ATM Gene Polymorphisms with Papillary Thyroid Cancer

Association of ATM Gene Polymorphism with PTC Metastasis in Female Patients

Association Between ATM Rs1801516 Polymorphism and Cancer Susceptibility: a Meta-Analysis Involving 12,879 Cases and 18,054 Controls

Discovery of a Pathogenic Variant Rs139379666 (p. P2974L) in ATM for Breast Cancer Risk in Chinese Populations

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk

ATM Polymorphisms Are Associated with Radiosensitivity for Patients with Esophageal Squamous Cell Carcinoma Underwent Preoperative Radiation Therapy

A Pleiotropic ATM Variant (rs1800057 C>G) is Associated with Risk of Multiple Cancers

Functional Polymorphism Rs189037 in the Promoter Region of ATM Gene is Associated with Angiographically Characterized Coronary Stenosis

Single Nucleotide Polymorphism in ATM and Non-Small Cell Lung Cancer Susceptibility

Ataxia Telangiectasia-Mutated (atm)polymorphisms and Risk of Lung Cancer in a Chinese Population

The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis

ATM sequence variants associate with susceptibility to non-small cell lung cancer.

The association of single nucleotide polymorphism rs189037C>T in ATM gene with coronary artery disease in Chinese Han populations: A case control study.

The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis

Relationships of FOXE1 and ATM Genetic Polymorphisms with Papillary Thyroid Carcinoma Risk: a Meta-Analysis

The Association of ATM Alterations with Clinical and Molecular Features in Metastatic Castration-Resistant Prostate Cancer.

Polymorphism rs189037C > T in the promoter region of the ATM gene may associate with reduced risk of T2DM in older adults in China: a case control study

ATM polymorphisms and risk of lung cancer among never smokers

Association between ATM 5557G>A polymorphism and breast cancer risk: a meta-analysis

ATM polymorphisms as risk factors for prostate cancer development

Gene-environment Interaction for Polymorphisms in Ataxia Telangiectasia-Mutated Gene and Radiation Exposure in Carcinogenesis: Results from Two Literature-Based Meta-Analyses of 27120 Participants